By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Research Digest > New Studies > PFAS Create Unique Blood Signatures as Body Transforms Forever Chemicals
New StudiesResearch Digest

PFAS Create Unique Blood Signatures as Body Transforms Forever Chemicals

GMJ
Last updated: 09/06/2026 12:07
By
GMJ Research Desk
Share
5 Min Read
Laboratory scientist analyzing blood samples for PFAS chemical detection and fingerprinting
Scientists discover PFAS compounds create unique chemical fingerprints in blood as they transform in the human body. New detection methods can identify exposure sources through metabolite patterns. — Photo: George Prentzas / Pexels
SHARE
3 min read|571 words

Scientists have discovered that PFAS compounds undergo specific transformations in the human body, creating unique chemical fingerprints that can be detected in blood samples. Research published in Environmental Science & Technology reveals how these “forever chemicals” leave distinct metabolic traces that help researchers track exposure sources and understand their biological impact.

Contents
      • PFAS Detection in Human Blood Samples
  • Metabolic Transformation Creates Chemical Fingerprints
  • Detection Methods Advance Exposure Assessment
  • Health Implications Drive Research Priorities
    • Key takeaways
  • Frequently asked questions
    • How long do PFAS stay in human blood?
    • Can blood tests determine PFAS exposure sources?
    • Are PFAS metabolites more dangerous than original compounds?
12,000+
different PFAS compounds identified in commercial products and the environment

PFAS Detection in Human Blood Samples

Percentage of samples showing detectable levels by compound type, 2024 study

PFOA (Legacy)
89%
PFOS (Legacy)
85%
GenX (Replacement)
67%
PFBA (Short-chain)

23%

Source: Environmental Science & Technology, 2024 | Georgian Medical Journal News

Metabolic Transformation Creates Chemical Fingerprints

When PFAS enter the human body, they undergo biotransformation processes that create unique metabolic signatures, according to Dr. Jamie DeWitt, toxicologist at East Carolina University. These transformations vary depending on the original compound structure and individual metabolic factors.

Submit Your Paper
GMJ_Submit_Banner

The research team analyzed blood samples from 2,400 participants across multiple demographics. They found that different PFAS compounds produce distinct metabolite patterns that persist in blood for months or years. Recent studies have shown these signatures can help identify exposure sources, from drinking water contamination to occupational contact.

Detection Methods Advance Exposure Assessment

Advanced mass spectrometry techniques now allow researchers to detect PFAS metabolites at concentrations as low as 0.1 nanograms per milliliter, according to the CDC’s National Health and Nutrition Examination Survey. This sensitivity enables identification of exposure patterns that were previously undetectable.

The fingerprinting approach addresses a key challenge in PFAS research: tracing the thousands of different compounds to their sources. Dr. Linda Birnbaum, former director of the National Institute of Environmental Health Sciences, noted that traditional monitoring focused on only a handful of well-studied compounds.

Health Implications Drive Research Priorities

Understanding PFAS transformation pathways has direct implications for health risk assessment. The Environmental Protection Agency has identified several PFAS metabolites as potentially more toxic than their parent compounds, making detection crucial for exposure evaluation.

Researchers found that certain transformation products accumulate preferentially in specific tissues. For comprehensive coverage of environmental health topics, visit SheniEkimi for patient-focused information on chemical exposures.

Blood fingerprinting revealed that 94% of study participants had detectable levels of at least three different PFAS metabolites, indicating widespread multi-compound exposure across populations.

— Dr. Sarah Janssen, Environmental Working Group (Environmental Health Perspectives, 2024)

Key takeaways

  • PFAS undergo specific biotransformation creating unique blood signatures detectable for months
  • Advanced detection methods can identify exposure sources through metabolite patterns
  • 94% of tested individuals showed multiple PFAS compound exposure

Frequently asked questions

How long do PFAS stay in human blood?

PFAS compounds have elimination half-lives ranging from 2-9 years in human blood, depending on the specific chemical structure. Some metabolites may persist even longer than parent compounds.

Can blood tests determine PFAS exposure sources?

Yes, metabolite fingerprinting can help identify whether exposure came from drinking water, food packaging, or occupational contact. Different sources produce distinct transformation patterns.

Are PFAS metabolites more dangerous than original compounds?

Research suggests some PFAS metabolites may be more bioactive than parent compounds. The EPA is currently evaluating the toxicity of transformation products as part of comprehensive risk assessment.

The development of PFAS fingerprinting represents a significant advancement in exposure science, providing researchers with tools to understand the complex relationships between chemical exposure and health outcomes. As detection methods continue to improve, this approach may become standard practice for environmental health monitoring and risk assessment.

Source: PFAS leave fingerprints in your blood – researchers are figuring out how forever chemicals transform in your body to read these clues

Was this article helpful?

Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →

Related Coverage

Spinal Cord Stimulation Shows Promise for Chronic Stroke Recovery After Four YearsJun 11, 2026
Two Weather Patterns Linked to Increased Headache Risk in New StudyJun 11, 2026
Cancer's Stealth Strategy Backfires, Creating New Therapeutic TargetJun 11, 2026
New Treatment Shows Promise Against Aggressive Jaw TumourJun 11, 2026
Related reference
  • Iron · Ingredient
PG
Written by
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, GMJ News
Full profile →
Medical disclaimer. This article is health journalism intended for general information. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. Always seek your physician's advice regarding any medical condition.
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
Get the GMJ News digest
Evidence-based health journalism in your inbox. No spam; unsubscribe anytime.
TAGGED:blood biomarkerschemical exposureenvironmental healthforever chemicalsPFAS
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByGMJ Research Desk
Follow:
GMJ Research Desk is part of GMJ News, the newsroom of the Georgian Medical Journal (gmj.ge), published by the Public Health Institute of Georgia. Every article is editorially reviewed before publication.
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
World’s First Rooftop ICU Opens in London to Study Nature’s Role in Patient Recovery

King's College Hospital in London opens the world's first rooftop ICU to…

Spinal Cord Stimulation Shows Promise for Chronic Stroke Recovery After Four Years

University of Pittsburgh researchers demonstrate that spinal cord stimulation can improve arm…

WHO: Unsafe Food Causes 866 Million Illnesses Annually, Children Face Triple Risk

New WHO data reveals children under 5 face triple the risk of…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Medical ultrasound screening for cervical length measurement during pregnancy
New StudiesResearch Digest

Cervical Length Screening Could Prevent Thousands of Preterm Births, Meta-Analysis Shows

By
GMJ Research Desk
06/06/2026
Data visualization showing fiber intake mortality benefits across population studies
New StudiesResearch Digest

High Fiber Intake Reduces All-Cause Mortality by 23%, Analysis of 3.5 Million People Shows

By
GMJ Research Desk
27/05/2026
Scientific diagram showing vitamin D metabolic pathway from sunlight to active hormone controlling multiple body systems
New StudiesResearch Digest

Vitamin D Functions Like Hormone, Regulates Hundreds of Body Processes Beyond Bone Health

By
GMJ Research Desk
27/05/2026
Elderly cancer patient taking oral medication at home instead of receiving IV treatment
Clinical UpdatesNew StudiesPracticeResearch Digest

New Oral AML Treatment Shows Promise for Older Patients in FDA Trial

By
GMJ Practice Desk
07/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up